Company intelligence / Profile preview

ArisGlobal

Miami, Florida, United Statesarisglobal.com ↗

Ownership: Private
Employees: ~1315
Development stage: Commercial

Overview

ArisGlobal provides the LifeSphere® platform—a suite of AI-powered SaaS solutions for life sciences companies to automate and optimize drug development processes including safety monitoring (pharmacovigilance), regulatory compliance, clinical development management, and medical affairs. The company’s software is used by over 500 organizations worldwide—including pharmaceutical firms, CROs, and health authorities—to streamline workflows and improve efficiency across the R&D lifecycle. Recent innovations include advanced generative AI features via NavaX and new safety signal analytics with LifeSphere Clarity.

Industry: Biomedical IT and Biomedical Data Platforms

Beyond the preview

Go deeper on ArisGlobal.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ArisGlobal.

Explore the full profile